|
|
Science Sparks @ ACTREC
|
21 November 2022 |
Vol. No. 11; Issue No. 553 |
|
Publications
|
1. Ostwal V, Ramaswamy A, Bhargava P, Srinivas S, Mandavkar S, Chaugule D, Peelay Z, Baheti A, Tandel H, Jadhav V, Shinde S, Jadhav S, Gota V, Mittra I (2023). A pro‑oxidant combination of resveratrol and copper reduces chemotherapy‑related non‑haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single‑arm study (RESCU III study). Medical Oncology. 40:17.
2. Mukund Sudharsan MG, Dalvi S, Venkatraman P (2022). Snapshots of urea-induced early structural changes and unfolding of an ankyrin repeat protein at atomic resolution. Protein Science.
3. D'Silva SZ, Tambe M, Pinto AS, Singh M (2022). Identification of the novel HLA-DQA1*01:01:01:11 and -DQA1*01:03:01:13 alleles in individuals from India. HLA.
4. Barrios C, de Lima Lopes G, Yusof MM, Rubagumya F, Rutkowski P, Sengar M (2022). Barriers in access to oncology drugs - A global crisis. Nature Reviews Clinical Oncology
5. Krishnamurthy R, Mummudi N, Goda JS, Chopra S, Heijmen B, Swamidas J (2022). Using artificial intelligence for optimization of the processes and resource utilization in radiotherapy. JCO Global Oncology
6. Bhatia N, Vatsa R, Dhingra VK, Dhawan DK, Chadha VD (2022). Evaluation of tetrofosmin cold kit fractionation using alternative new method of quality control for testing radiochemical purity. World Journal of Nuclear Medicine. 21(4): 314-319.
|
|
|
Interesting Reads
|
Sridaran D, Chouhan S, Mahajan K, Renganathan A, Weimholt C, Bhagwat S, Reimers M, Kim EH, Thakur MK, Saeed MA, Pachynski RK, Seeliger MA, Todd Miller W, Feng FY, Mahajan NP. Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance. Nat Commun. 13(1): 6929, 2022.
|
|
Legends of Science
|
|
Krishna Sahani Bilgrami
Krishna Sahani Bilgrami received his DSc from the University of Allahabad in 1962. His research interest was in fungal physiology, mycotoxicology, and ecology. He demonstrated the significance of transglycosylation in bread and fungi's utilization of complex carbohydrates. He studied the impact of industrial and urban effluents on the biodiversity of river Ganga and thermal springs in Bihar, as well as the effect of various mycotoxins on critical physiological and biochemical processes of animals and plants. He was a member of the Ganga Project Directorate Research Committee, Agricultural Research Committee, Wetland Management Committee, and ICMR Taskforce Committee. He was a Member of the INSA Council (1992-93). 'Professor Krishna Bilgrami Memorial Medal' was instituted in his honor by the INSA.
|
|
|
|
Himadri Kumar Mookerjee
Himadri Kumar Mookerjee obtained his DSc from the University of London in 1930. His specialization was embryology of vertebral columns and later fisheries. He postulated the hypothesis of a common structural basis for the development and evolution of the vertebral centra in the chordates. He did significant work on the development of the vertebral column from the embryonic state and the evolution of the column. He set forth that the modes of formation of the centra follow the same pattern in all the chordates. He was a member Asiatic Society, Vice-President (1955); He served as the President Indian Science Congress (1936).
|
|
|
|
|
Do You Know?
In 1994, FDA approved BCG, a bacterial vaccine, for the treatment of bladder cancer, based on results of a clinical trial conducted by Memorial Sloan Kettering urologic surgeon Harry Herr and tumor immunologist Herbert Oettgen.
|
|
|
Cancer News
|
Lab-grown bone marrow may unlock personalized blood cancer treatments
|
16 November 2022, NEW ATLAS
|
By using stem cells as a starting point, scientists have managed to produce lab-grown versions of an impressive array of human body parts. The list so far includes brains, blood vessels and lungs, and is growing rapidly, with these miniaturized models serving as next-gen research tools to study disease and develop drugs that can improve outcomes for patients...
|
|
|
|
|
|
|
|
|
� 2022 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|